Wegovy Price: A Complete 2026 Guide to Costs, Coverage, and Savings

If you're considering Wegovy for weight management, understanding the actual cost is crucial. Wegovy pricing varies significantly based on insurance coverage, dosage, pharmacy choice, and available discounts. In this comprehensive guide, we'll break down exactly what you can expect to pay for Wegovy and how to find the most affordable options available to you.

Understanding Wegovy Pricing Basics

Wegovy is a prescription injectable medication containing semaglutide, approved by the FDA for chronic weight management. Unlike many other weight loss medications, Wegovy's pricing structure can be complex. The base cost without insurance typically ranges from $1,349 to $1,550 per month for a single dose pen, depending on your pharmacy and location.

Most patients don't pay the full list price, however. Insurance coverage, manufacturer coupons, and discount programs can reduce your out-of-pocket expenses significantly. The actual price you pay depends on multiple factors including your insurance plan type, deductible status, and preferred pharmacy network.

Wegovy Dosages and Their Costs

Wegovy comes in four different dose strengths: 0.25mg, 0.5mg, 1mg, and 2.4mg. Most patients start with the lowest dose and gradually increase over 16 weeks to reach the maximum maintenance dose of 2.4mg per week. Each dose level has a different price point, affecting your total treatment cost.

The starting dose of 0.25mg typically costs around $249 to $349 per month for uninsured patients. As you progress to higher doses, prices increase proportionally. The full maintenance dose of 2.4mg can cost $1,300 to $1,550 monthly without insurance. However, most patients spend their first four months at lower doses while titrating up, which can reduce initial treatment costs. Understanding which dose your doctor prescribes is essential for accurate budget planning.

Insurance Coverage and Out-of-Pocket Costs

Insurance coverage dramatically impacts your Wegovy expenses. Many major insurers, including Aetna, United Healthcare, Cigna, and Humana, now cover Wegovy when prescribed for weight management. With insurance, your out-of-pocket cost typically ranges from $50 to $550 per month, depending on your plan's copay structure and whether you've met your deductible.

Plans with high deductibles may require you to pay the full pharmacy price until you reach your deductible amount. Once deductibles are met, copays generally decrease significantly. Some insurance plans categorize Wegovy as a specialty drug, which may result in higher copays—sometimes 25 to 33 percent of the drug cost. It's worth contacting your insurance provider directly to understand your specific coverage before starting treatment.

Patients without insurance face the full list price, but multiple assistance programs exist. Novo Nordisk, the manufacturer, offers the Novo Care program, which can reduce costs for eligible uninsured or underinsured patients. This program has helped thousands of people access Wegovy for as little as $99 per month.

Discount Programs and Ways to Save on Wegovy

Several legitimate programs can reduce your Wegovy costs regardless of insurance status. GoodRx, SingleCare, and similar prescription discount platforms often provide significant savings at participating pharmacies. These programs can cut Wegovy costs by 10 to 40 percent compared to the standard retail price.

The Novo Care Savings program offers tiered pricing based on household income. Eligible patients with household incomes up to 400 percent of the federal poverty level may qualify for $99 monthly doses. Those with higher incomes still receive discounts, typically paying $250 to $750 monthly depending on their income level.

Comparison shopping across pharmacies is another effective strategy. Prices vary between independent pharmacies, major chains like CVS and Walgreens, and mail-order services. Some patients save $200 to $400 monthly by switching pharmacies. Additionally, some telehealth providers bundle medication costs with consultations, occasionally offering package pricing that reduces overall expenses.

Additional Costs Beyond the Medication

The Wegovy price isn't just the medication itself. You'll need to factor in doctor visits for prescriptions and monitoring. Initial consultations with a healthcare provider typically cost $100 to $300, with follow-up visits running $75 to $200 each. Most patients require monthly or quarterly check-ins during treatment.

If you're purchasing through telehealth services, subscription costs range from $50 to $300 monthly depending on the platform. Some telehealth providers include doctor visits in their membership, while others charge separately. Patients should also budget for potential side effects management—anti-nausea medications or dietary supplements may add $20 to $100 monthly to your total treatment cost.

Finding the Best Wegovy Price for Your Situation

The best way to determine your actual Wegovy cost is gathering information specific to your situation. Start by contacting your insurance company to confirm coverage and copay amounts. Call several local pharmacies and use online discount programs to compare prices. Ask your doctor about patient assistance programs offered by Novo Nordisk.

Don't assume the first price quote is your best option. The difference between the most expensive and most affordable options for the same medication can exceed $500 monthly. Taking time to research your options upfront can save thousands of dollars over your treatment course.

Our free GLP-1 cost calculator at glp1costcalculator.com helps you estimate your personalized Wegovy costs based on your insurance type, dosage, and location. This tool removes the guesswork from pricing and provides accurate out-of-pocket estimates in seconds.

Frequently Asked Questions

Does insurance typically cover Wegovy for weight loss?

Many major insurance plans now cover Wegovy for chronic weight management, though coverage varies by plan and provider. Most insurers require documentation of previous weight loss attempts and a BMI of 30 or higher, or 27 with weight-related conditions. Contact your specific insurance provider to confirm your coverage details and any prior authorization requirements.

What's the cheapest way to get Wegovy?

The cheapest option depends on your insurance status. Insured patients should verify their copay; uninsured patients should explore the Novo Care program offering $99 monthly doses for eligible individuals. Additionally, using prescription discount apps like GoodRx and comparing prices across pharmacies can reduce costs by 10 to 40 percent.

Is Wegovy more expensive than Ozempic?

Wegovy and Ozempic contain the same active ingredient (semaglutide) but are marketed differently. Ozempic is FDA-approved for diabetes, while Wegovy targets weight loss—yet they're typically priced identically at the pharmacy. Some insurance plans may cover one but not the other, making comparative research important for your specific situation.

How long do patients typically stay on Wegovy?

Most patients continue Wegovy as long as they're experiencing benefits and tolerating it well. The medication is designed for long-term use, with studies showing sustained weight loss over two years or more. Your doctor can help determine your optimal treatment duration based on your response and health goals.

Can I use coupons with insurance to pay for Wegovy?

Generally, manufacturer coupons cannot be combined with insurance coverage. However, if your insurance copay is higher than a manufacturer coupon discount, you typically use the lower amount. Verify coupon terms and confirm with your pharmacy about their specific policies regarding coupon and insurance combinations.

Conclusion

Wegovy pricing ranges dramatically based on insurance coverage, dosage, and available discounts, with monthly costs ranging from $99 for eligible uninsured patients to $1,550 for full-price uninsured patients at maintenance doses. Understanding your specific situation—including your insurance benefits, qualifying discount programs, and pharmacy options—is essential for managing Wegovy costs effectively. By researching your options thoroughly and leveraging available assistance programs, you can significantly reduce your out-of-pocket expenses while accessing this effective weight management medication.

Use Our Free GLP-1 Cost Calculator

Stop guessing about your Wegovy costs. Head to glp1costcalculator.com today and use our free GLP-1 cost calculator to get your personalized pricing breakdown. Simply enter your insurance type, dosage level, and zip code to instantly receive specific dollar amounts showing your estimated out-of-pocket costs, potential insurance copays, and available savings through discount programs. Find out exactly what you'll pay for Wegovy and discover the most affordable options in your area—all in seconds, with no signup required.

Wegovy Price in 2026 vs 2024 What Changed and Why

If you filled a Wegovy prescription in 2024, you may notice the pricing landscape looks meaningfully different in 2026 — and understanding those shifts can directly affect your wallet.

In early 2024, Wegovy's list price sat at approximately $1,349 per month for the 2.4 mg maintenance dose, a figure that held largely flat into 2026. However, the *effective* price most patients pay has changed due to several market forces.

**Expanded insurance coverage:** Following the landmark SELECT cardiovascular outcomes trial showing a 20% reduction in major cardiovascular events, the FDA expanded Wegovy's indication in March 2024 to include cardiovascular risk reduction. This opened the door for Medicare Part D coverage — previously blocked under anti-obesity medication restrictions — for patients with established cardiovascular disease. By 2026, this change has translated into broader formulary inclusion across both public and private payers.

**Employer plan adoption:** Large self-insured employers accelerated Wegovy coverage decisions in 2025–2026 after early data showed reduced downstream costs in cardiovascular hospitalizations and diabetes management. Analysts estimate 15–20% more employer-sponsored plans now cover Wegovy compared to 2024, which meaningfully reduces out-of-pocket exposure for commercially insured patients.

**Compounded semaglutide regulation:** During the 2023–2024 shortage, FDA-registered compounding pharmacies legally produced semaglutide alternatives at $200–$500/month, creating de facto price competition. The FDA's resolution of the shortage designation and 2025–2026 enforcement actions against compounders effectively narrowed this lower-cost pathway, pushing some patients back toward brand-name pricing or telehealth programs offering structured savings access.

**International pricing pressure:** While the U.S. list price remains among the highest globally — Wegovy costs approximately $140/month in Germany and $200/month in Canada — ongoing policy discussions around the Inflation Reduction Act drug negotiation framework have not yet directly impacted Wegovy's pricing as of 2026. However, increased political scrutiny continues.

The net result: patients with good commercial insurance are paying less than ever (sometimes $0–$25/month), while uninsured patients continue to face the highest structural burden at $650–$1,349/month.

Wegovy Cost Calculator Your Personalized Price Estimate

Because Wegovy pricing is highly individualized, a single published number rarely reflects what you'll actually pay. Several key variables determine your true monthly cost — and walking through them systematically is the most reliable way to estimate your out-of-pocket burden before your first fill.

**Step 1 — Identify your insurance status:** - *Commercial insurance (employer or marketplace):* Check your plan's drug formulary for semaglutide or Wegovy. Tier placement determines your copay. Tier 3 specialty drugs typically run $80–$200/month before any savings card; with the Novo Nordisk WegovyTogether card, eligible patients can reduce this to $25/month. - *Medicare Part D:* If you have documented cardiovascular disease, your plan may now cover Wegovy. Under the 2025 Medicare Part D redesign, annual out-of-pocket drug costs are capped at $2,000, limiting maximum exposure to approximately $167/month even at specialty pricing. - *Medicaid:* Coverage and cost-sharing vary by state. Use your state Medicaid formulary or call your managed care plan directly. - *Uninsured:* Proceed to Step 3.

**Step 2 — Confirm your prescribed dose:** Wegovy is initiated at 0.25 mg weekly and titrated every 4 weeks up to the 2.4 mg maintenance dose. Your current dose affects your monthly cost, since lower titration doses carry lower list prices ($935–$1,050/month at 0.25–0.5 mg) versus the full maintenance price of $1,349/month.

**Step 3 — Apply available discount programs:** Uninsured patients should compare: - GoodRx: $650–$900/month at major retail chains - NovoCare Patient Assistance: $0 if income-eligible - Telehealth platforms (Ro, Calibrate, Found): Often include bundled pricing with prescriber visits

**Step 4 — Factor in additional costs:** Add $50–$150/month for required follow-up visits, $0–$75 for lab work (fasting lipids, HbA1c if applicable), and potential $10–$30 for injection supplies depending on your pharmacy.

Use our free GLP-1 Cost Calculator at the bottom of this page to enter your specific variables and generate a personalized monthly estimate in under 60 seconds.

Wegovy Shortage Impact on Pricing in 2026

The Wegovy shortage that began in 2022 and persisted through much of 2023–2024 had a paradoxical effect on pricing: it simultaneously drove patients toward lower-cost compounded alternatives while making brand-name Wegovy harder to access regardless of price.

By mid-2024, Novo Nordisk significantly expanded manufacturing capacity through its Kalundborg, Denmark facility and new U.S. partnerships, and the FDA removed Wegovy from its official drug shortage list. This resolution had several downstream pricing implications that are still playing out in 2026.

**Compounded semaglutide exit:** During peak shortage, FDA enforcement discretion allowed 503A and 503B compounding pharmacies to produce semaglutide. Prices ranged from $199–$500/month through telehealth platforms — a fraction of brand-name costs. The shortage resolution triggered FDA enforcement actions beginning in late 2024, requiring most compounders to cease production. By 2026, the compounded pathway is substantially narrowed, though some 503A pharmacies continue to serve patients with documented allergies or specific formulation needs. This closure removed a meaningful low-cost option for uninsured and underinsured patients.

**Pharmacy stocking variability:** Even post-shortage designation removal, regional supply chain inconsistencies persist in 2026, particularly for lower titration doses (0.25 mg and 0.5 mg pens). Some patients have reported switching pharmacies to find available stock, which occasionally affects pricing through different pharmacy discount tier agreements.

**Price stability at list level:** The shortage itself did not cause Novo Nordisk to raise or lower the list price — $1,349/month has held consistent since late 2023. However, the competitive pressure from compounders arguably suppressed any list price increases during 2024–2025. With that competitive force diminished in 2026, analysts are watching for potential incremental price adjustments, though political and payer pressure provides a countervailing force.

**What this means for you:** If you relied on compounded semaglutide as a cost strategy in 2024, you likely need to revisit your options in 2026. This makes understanding manufacturer savings programs, patient assistance eligibility, and employer benefit negotiations more important than ever.

How BMI and Dosage Affect Your Wegovy Total Cost

Two clinical factors that are often overlooked in Wegovy cost discussions are your starting BMI and how your body responds to titration — both of which directly influence how much you'll spend over a 12-month treatment course.

**Dosage titration timeline and cost:** Wegovy follows a mandatory 16-week titration schedule before patients reach the 2.4 mg maintenance dose: - Weeks 1–4: 0.25 mg/week (~$935/month list price) - Weeks 5–8: 0.5 mg/week (~$985/month list price) - Weeks 9–12: 1.0 mg/week (~$1,100/month list price) - Weeks 13–16: 1.7 mg/week (~$1,200/month list price) - Week 17+: 2.4 mg/week (~$1,349/month list price)

This means your average first-year cost is *lower* than 12 months at maintenance price. A patient who starts Wegovy in January 2026 and reaches maintenance dose in May pays approximately $13,500–$14,800 at list price for the first year, not the $16,188 that 12 months of maintenance pricing would suggest.

**Dose tolerability and cost variability:** Approximately 10–15% of patients cannot tolerate the full 2.4 mg dose due to gastrointestinal side effects and remain on 1.7 mg long-term. At $1,200/month list price, this actually reduces annual costs by approximately $1,800 compared to the maximum dose — an unintended financial benefit of dose reduction.

**BMI and treatment duration:** Research indicates patients with higher starting BMI (≥40) typically require longer treatment duration to achieve and sustain goal weight loss. Since Wegovy is generally considered a lifelong therapy for weight maintenance, higher-BMI patients face proportionally greater lifetime costs. However, higher BMI also often correlates with more comorbidities, which can strengthen insurance coverage arguments and qualify patients for manufacturer assistance programs.

**Response-based cost efficiency:** Clinical guidelines recommend assessing Wegovy response at 16 weeks. Patients who have not lost at least 5% of body weight by that point are typically counseled to discontinue. For cost-planning purposes, this means patients can build in a defined 4-month evaluation window before committing to long-term budget planning — a practical approach when weighing Wegovy's price against expected health outcomes.

Frequently Asked Questions — Additional

What is the Wegovy price in 2026?

The list price of Wegovy in 2026 is approximately $1,349 per month for a 4-week supply of the maintenance dose (2.4 mg). However, most patients do not pay this amount. With the Novo Nordisk savings card, commercially insured patients may pay as little as $0–$25 per month. Uninsured patients typically pay $650–$1,100 per month through discount programs like GoodRx or Mark Cuban's Cost Plus Drugs. Prices vary based on your dose, pharmacy, location, and insurance status.

How much does Wegovy cost per month in 2026?

Your monthly Wegovy cost in 2026 depends heavily on your insurance and dosage. With good commercial insurance coverage, patients pay $0–$25/month using manufacturer savings cards. Medicare Part D enrollees face variable costs, typically $0–$106/month under the 2025 redesign cap, though obesity-specific coverage remains limited. Without insurance, expect $650–$1,349/month depending on the dose and pharmacy discount used. The starting dose (0.25 mg) costs roughly $935/month at list price, while the maintenance dose (2.4 mg) reaches $1,349/month.

How much does Wegovy cost without insurance in 2026?

Without insurance in 2026, the cash price for Wegovy ranges from approximately $935 to $1,349 per month depending on your prescribed dose. Using pharmacy discount cards such as GoodRx, Blink Health, or RxSaver, uninsured patients can reduce this to roughly $650–$900/month at participating pharmacies. The Novo Nordisk NovoCare Patient Assistance Program offers Wegovy at no cost to patients who meet income eligibility requirements (generally under 400% of the federal poverty level and without insurance coverage). Compounded semaglutide from FDA-registered pharmacies, while not FDA-approved as a finished product, has been available for $200–$500/month, though regulatory status changes in 2026 may affect availability.

Is Wegovy covered by insurance in 2026?

Insurance coverage for Wegovy in 2026 remains inconsistent. Approximately 50–60% of commercial health plans now cover Wegovy for obesity treatment when prescribed with a BMI ≥30, or ≥27 with a weight-related comorbidity such as type 2 diabetes, hypertension, or high cholesterol. The 2022 Treat and Reduce Obesity Act (TROA) passage momentum has pushed more employers to include GLP-1 coverage, but adoption is still not universal. Medicare covers Wegovy for cardiovascular risk reduction (following the SELECT trial data) under Part D for patients with established cardiovascular disease, but coverage for obesity alone remains restricted under most Medicare plans. Medicaid coverage varies significantly by state — as of 2026, roughly 30 states include some GLP-1 obesity coverage. Always verify your specific plan's formulary before assuming coverage.

How much does Wegovy cost with the Novo Nordisk savings card in 2026?

The Novo Nordisk Wegovy savings card (WegovyTogether program) in 2026 allows eligible commercially insured patients to pay as little as $0 for a 1-month trial supply and $25/month for subsequent fills, with a maximum savings cap that varies by program terms. Patients who do not have commercial insurance — including those on Medicare, Medicaid, or government-funded plans — are not eligible for the manufacturer savings card. Income-eligible uninsured patients should instead apply for the NovoCare Patient Assistance Program. The savings card must be used at participating retail pharmacies, and eligibility is subject to annual program renewal by Novo Nordisk.